Two-Stage Exchange Arthroplasty for Periprosthetic Shoulder Infection Is Associated with High Rate of Failure to Reimplant and Mortality.
mortality
periprosthetic shoulder infection
reimplantation
two-stage exchange
Journal
Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588
Informations de publication
Date de publication:
06 Nov 2021
06 Nov 2021
Historique:
received:
17
10
2021
revised:
30
10
2021
accepted:
02
11
2021
entrez:
13
11
2021
pubmed:
14
11
2021
medline:
14
11
2021
Statut:
epublish
Résumé
Patients with a periprosthetic joint infection (PJI) of the shoulder, who fail to undergo reimplantation in an attempted two-stage exchange seem to be neglected in the current literature. The aim of this study was to assess the clinical course of patients after the first stage in the process of an attempted two-stage exchange for shoulder PJI. After a retrospective review of our institutional database between 2008 and 2018, 49 patients, who were treated with an intended two-stage exchange for shoulder PJI, were identified. Patients' demographics, laboratory and health status parameters, along with records of clinical outcome were collected. The primary outcome measurements analyzed were infection eradication, successful reimplantation, and patient survival. Reimplantation was completed in only 35 (71%) of 49 cases and eradication of infection was achieved in 85.7% of patients with successful reimplantation after a mean follow-up duration of 5.1 years (1.1 to 10.2 years). Reasons for failure to reimplant were premature death in 36%, high general morbidity in 29%, satisfaction with the current status in 21%, or severe infection with poor bone and soft tissues in 14% of the patients. Of the 14 cases without reimplantation, eradication rate of infection was 57% after a mean follow-up of 5 years (2.6 to 11 years). The overall mortality rate of the entire cohort was 25% at the latest follow-up and 10% within ninety days after implant removal. Patients who deceased or did not undergo reimplantation during the follow-up were significantly older and had a significantly higher Charlson comorbidity index (CCI). While the two-stage exchange arthroplasty can lead to high rates of infection eradication, a considerable subset of patients never undergoes the second stage for a variety of reasons. Shoulder PJI and its treatment are associated with a high risk of mortality, especially in patients with older age and higher CCI.
Sections du résumé
BACKGROUND
BACKGROUND
Patients with a periprosthetic joint infection (PJI) of the shoulder, who fail to undergo reimplantation in an attempted two-stage exchange seem to be neglected in the current literature. The aim of this study was to assess the clinical course of patients after the first stage in the process of an attempted two-stage exchange for shoulder PJI.
METHODS
METHODS
After a retrospective review of our institutional database between 2008 and 2018, 49 patients, who were treated with an intended two-stage exchange for shoulder PJI, were identified. Patients' demographics, laboratory and health status parameters, along with records of clinical outcome were collected. The primary outcome measurements analyzed were infection eradication, successful reimplantation, and patient survival.
RESULTS
RESULTS
Reimplantation was completed in only 35 (71%) of 49 cases and eradication of infection was achieved in 85.7% of patients with successful reimplantation after a mean follow-up duration of 5.1 years (1.1 to 10.2 years). Reasons for failure to reimplant were premature death in 36%, high general morbidity in 29%, satisfaction with the current status in 21%, or severe infection with poor bone and soft tissues in 14% of the patients. Of the 14 cases without reimplantation, eradication rate of infection was 57% after a mean follow-up of 5 years (2.6 to 11 years). The overall mortality rate of the entire cohort was 25% at the latest follow-up and 10% within ninety days after implant removal. Patients who deceased or did not undergo reimplantation during the follow-up were significantly older and had a significantly higher Charlson comorbidity index (CCI).
CONCLUSIONS
CONCLUSIONS
While the two-stage exchange arthroplasty can lead to high rates of infection eradication, a considerable subset of patients never undergoes the second stage for a variety of reasons. Shoulder PJI and its treatment are associated with a high risk of mortality, especially in patients with older age and higher CCI.
Identifiants
pubmed: 34768706
pii: jcm10215186
doi: 10.3390/jcm10215186
pmc: PMC8584704
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
J Clin Med. 2021 Jan 09;10(2):
pubmed: 33435442
N Engl J Med. 2004 Oct 14;351(16):1645-54
pubmed: 15483283
JBJS Rev. 2019 Jul;7(7):e3
pubmed: 31291202
J Arthroplasty. 2020 May;35(5):1384-1389
pubmed: 31902617
J Arthroplasty. 2019 Nov;34(11):2749-2756
pubmed: 31285090
Int J Oral Sci. 2011 Apr;3(2):55-65
pubmed: 21485309
J Shoulder Elbow Surg. 2020 Jun;29(6):e222-e228
pubmed: 31924518
J Shoulder Elbow Surg. 2017 Jun;26(6):939-947
pubmed: 27887875
J Shoulder Elbow Surg. 2019 Sep;28(9):1658-1665
pubmed: 31208895
Arch Orthop Trauma Surg. 2021 Jan 30;:
pubmed: 33515325
J Shoulder Elbow Surg. 2017 Nov;26(11):1978-1983
pubmed: 28751093
BMC Musculoskelet Disord. 2016 Feb 01;17:52
pubmed: 26832360
Arch Orthop Trauma Surg. 2018 May;138(5):635-642
pubmed: 29352435
J Shoulder Elbow Surg. 2010 Mar;19(2):303-7
pubmed: 19884021
J Shoulder Elbow Surg. 2019 Jun;28(6S):S8-S12
pubmed: 31196517
Shoulder Elbow. 2020 Dec;12(1 Suppl):70-80
pubmed: 33343718
Bone Joint J. 2017 Nov;99-B(11):1490-1495
pubmed: 29092988
Clin Orthop Relat Res. 2013 Jul;471(7):2374-82
pubmed: 23440616
HSS J. 2018 Oct;14(3):228-232
pubmed: 30258325
J Bone Joint Surg Am. 2015 Sep 16;97(18):1495-502
pubmed: 26378265
J Chronic Dis. 1987;40(5):373-83
pubmed: 3558716
J Orthop Surg Res. 2019 Mar 13;14(1):78
pubmed: 30866970
J Shoulder Elbow Surg. 2020 Sep;29(9):e325-e329
pubmed: 32245728
Clin Orthop Relat Res. 2018 Jan;476(1):146-152
pubmed: 29389759
J Shoulder Elbow Surg. 2020 Dec;29(12):2476-2486
pubmed: 32565412
Orthop Traumatol Surg Res. 2019 Apr;105(2):237-240
pubmed: 30497888
J Shoulder Elbow Surg. 2019 Jun;28(6S):S67-S99
pubmed: 31196516
J Bone Joint Surg Am. 2019 Feb 6;101(3):239-249
pubmed: 30730483